Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Follicular lymphoma, survival, and rituximab: is it time to declare victory?

× No keyword cloud information.

7 in total

1. Impact of Rituximab (Rituxan) on the Treatment of B-Cell Non-Hodgkin's Lymphoma.

Authors: Efrat Dotan; Charu Aggarwal; Mitchell R Smith
Journal: P T Date: 2010-03

2. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.

Authors: Nadia Howlader; Lindsay M Morton; Eric J Feuer; Caroline Besson; Eric A Engels
Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-10-15 Impact factor: 4.254

Review 3. Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.

Authors: Gillian M Keating
Journal: Drugs Date: 2010-07-30 Impact factor: 9.546

Review 4. Rituximab for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Authors: Fredrick Hagemeister
Journal: Drugs Date: 2010-02-12 Impact factor: 9.546

5. Modulation of deoxycytidine kinase (dCK) and glycogen synthase kinase (GSK-3β) by anti-CD20 (rituximab) and 2-chlorodeoxyadenosine (2-CdA) in human lymphoid malignancies.

Authors: Ayad M Al-Katib; Amro Aboukameel; AbdulShukkur Ebrahim; Frances Wj Beck; Samuel E Tekyi-Mensah; Ali Raufi; Yasin Ahmed; Mary Mandziara; Zyad Kafri
Journal: Exp Hematol Oncol Date: 2014-12-19

6. Analysis and prediction of relative survival trends in patients with non-Hodgkin lymphoma in the United States using a model-based period analysis method.

Authors: Shuping Xie; Zhong Yu; Aozi Feng; Shuai Zheng; Yunmei Li; You Zeng; Jun Lyu
Journal: Front Oncol Date: 2022-09-27 Impact factor: 5.738

7. A Case of Chronic Conjunctivitis following Rituximab Therapy.

Authors: Marnelli A Bautista; Walter D Y Quan; Jun Wang
Journal: Adv Hematol Date: 2009-09-01

7 in total